04/22/2024
3:06 PM | Astria Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:08 PM | Astria Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:10 PM | Astria Therapeutics (Filer)
| Form ARS | |
04/09/2024
7:07 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:09 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
7:11 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:37 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/11/2024
7:19 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
11:29 AM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:48 PM | Astria Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:36 AM | Astria Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
7:59 AM | Astria Therapeutics (Filer)
| Form 424B5 | |
01/31/2024
8:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:03 PM | Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:01 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:26 PM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:39 PM | Astria Therapeutics (Subject)
Morabito Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:30 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:16 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
01/01/2024
11:15 PM | Astria Therapeutics (Filer)
| Form EFFECT | |
12/28/2023
1:09 PM | Astria Therapeutics (Filer)
| Form S-3/A | |
12/22/2023
1:51 PM | Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:30 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
7:30 AM | Astria Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
7:06 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:11 PM | Astria Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/18/2023
3:11 PM | Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:01 PM | Astria Therapeutics (Filer)
| Form 424B5 | |
10/12/2023
4:04 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
6:24 PM | Astria Therapeutics (Subject)
| Form FWP | |
10/11/2023
4:14 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:00 AM | Astria Therapeutics (Issuer)
BATE KENNETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:02 AM | Astria Therapeutics (Issuer)
Beck Joanne T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:03 AM | Astria Therapeutics (Issuer)
Clauser Noah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:04 AM | Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:04 AM | Astria Therapeutics (Issuer)
Callori Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:05 AM | Astria Therapeutics (Issuer)
Cole Hugh M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
What is the 72-Hour Profit Surge? (Ad) One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge...
A short period of time where we can bet on a stock that is ALREADY “winning.”
Let me give you a perfect example of how the Surge worked with Ross Stores.
Back on November 16th, a little move was made that sent their stock soaring…
The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
KISHBAUCH MICHAEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:07 AM | Astria Therapeutics (Issuer)
Harshbarger Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:07 AM | Astria Therapeutics (Issuer)
Komjathy Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:08 AM | Astria Therapeutics (Issuer)
Matthews Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:08 AM | Astria Therapeutics (Issuer)
Milne Jill C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
11:15 PM | Astria Therapeutics (Filer)
| Form EFFECT | |
